Genetic Engineering News and Research

RSS

Rapid rise in Big Data facilitates digital transformation of healthcare

The unprecedented implications of digital health innovations, being co-produced by the mainstreaming and integration of artificial intelligence, the Internet of Things, and cyber-physical systems in healthcare, are examined in a new technology horizon-scanning article.

13 Jun 2019

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Apolipoproten E is a major genetic risk factor for the development of Alzheimer's disease, yet the protein tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease.

13 Jun 2019

New technology harnesses bacterial jumping genes for precise DNA integration

A new discovery by researchers at Columbia University Vagelos College of Physicians and Surgeons could fix one of the major shortcomings of current gene-editing tools, including CRISPR, and offer a powerful new approach for genetic engineering and gene therapy.

13 Jun 2019

Russian researcher announces plans to create more CRISPR-edited babies

A researcher has announced controversial plans to create gene-edited babies, dividing the scientific community.

12 Jun 2019

Study: Underweight boys and overweight girls have increased risk of depression

The results of a large community-based study have shown that the probability of major depressive disorder in children and adolescents with high, low, or normal body mass index differs according to gender.

12 Jun 2019

Malaria drug may help those with hereditary hearing loss finds study

Researchers have found that anti-malarial drug artemisinin could help patients with genetic or hereditary hearing loss. The study results were published in the latest issue of the journal Proceedings of the National Academy of Sciences (PNAS). The study was titled, “Unconventional secretory pathway activation restores hair cell mechanotransduction in an USH3A model.”

12 Jun 2019

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

11 Jun 2019

New case study about cannabis hyperemesis syndrome in palliative care

The medical use of cannabis is growing. Medical marijuana may improve symptoms including pain and anorexia. While it may improve nausea and vomiting, it can rarely cause a hyperemesis syndrome with chronic use.

11 Jun 2019

Unhealthy gut microbiome may make breast cancers more aggressive finds study

A new study from the researchers at the University of Virginia Cancer Center connects an unhealthy gut microbiome with breast cancer that can become invasive and spread to other organs faster. The results of the study were published in the latest issue of the journal Cancer Research.

10 Jun 2019

Foods enhanced with proven health benefits are stuck in 'development limbo', GM expert says

Many of the tools for tackling the global epidemics of malnutrition, obesity and their associated health problems are already with us, but are stuck in ‘development limbo’, according to an expert in GM technology.

6 Jun 2019

Gene-editing could shorten life instead of prolonging, suggests new study

In 2018, Chinese scientist He Jiankui defied the law and scientific consensus by boldly editing the CCR5 gene in a human embryo, expecting to confer lifelong HIV resistance. The pregnancy eventually ended in the birth of two baby girls. Now the experiment appears to have gone seriously wrong, perhaps shortening their lives.

4 Jun 2019

Lithium improves muscle size and strength in mice with limb girdle muscular dystrophy

Standing up from a chair, climbing stairs, brushing one's hair - all can be a struggle for people with a rare form of muscular dystrophy that causes progressive weakness in the shoulders and hips. Over time, many such people lose the ability to walk or to lift their arms above their heads.

3 Jun 2019

Body's endocannabinoid system appears to be new target for drug development against OCD

The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder.

3 Jun 2019